Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ORD SHS
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
6,991,387
-
Shares change
-
+4,853,220
-
Total reported value, excl. options
-
$144,509,520
-
Value change
-
+$104,648,380
-
Put/Call ratio
-
73%
-
Number of buys
-
36
-
Number of sells
-
-8
-
Price
-
$20.67
Significant Holders of NEURODERM LTD - ORD SHS as of Q3 2015
47 filings reported holding M74231107 - NEURODERM LTD - ORD SHS as of Q3 2015.
NEURODERM LTD - ORD SHS has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,991,387 shares
.
Largest 10 shareholders include Redmile Group, LLC (1,462,699 shares), SCOPIA CAPITAL MANAGEMENT LP (1,343,541 shares), venBio Select Advisor LLC (1,103,093 shares), Longwood Capital Partners LLC (496,630 shares), RA CAPITAL MANAGEMENT, LLC (425,000 shares), CADIAN CAPITAL MANAGEMENT, LP (419,315 shares), BAKER BROS. ADVISORS LP (305,000 shares), PERCEPTIVE ADVISORS LLC (270,000 shares), Arrowpoint Asset Management, LLC (124,290 shares), and MENORA MIVTACHIM HOLDINGS LTD. (109,826 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.